ProMIS Neurosciences
Tracked across 3 events · 19 articles · First seen Jul 14, 2026 · Last active Aug 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: ProMIS Neurosciences is the developer of PMN310; positive Phase 1a data supports its precision medicine approach and may enhance its valuation.
Jul 14, 2026 · 6 articles
Tech
Impact: ProMIS is hosting the webinar to discuss its lead candidate PMN310; the event is central to its clinical development.
Jul 27, 2026 · 6 articles
Business
Impact: ProMIS Neurosciences is the subject of the announcement, which details its upcoming Q2 2026 financial results and business update. The event is a routine disclosure that may affect investor perception based on the reported results and strategic updates.
Aug 03, 2026 · 7 articles
ERGEN INTELLIGENCE
Track ProMIS Neurosciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard